Viewing data from:

CEPHALEXIN

ANDA

CEPHALEXIN | A061969 | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA

2 strengths0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Cephalexin (2023)

Total Spending

$64.3M

Total Claims

7,112,512

Beneficiaries

5,051,787

Avg Cost/Unit

$0.37

Spending Trend

$48.8M(2019)→$42.9M(2020)→$47.6M(2021)→$58.7M(2022)→$64.3M(2023)

YoY Change:+4.6%

5yr CAGR:+6.1%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain8 active DMFs22 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

CENTRIENT PHARMACEUTICALS NETHERLANDS BVCEPHALEXIN MONOHYDRATE

DMF 132101998

ANTIBIOTICOS SACEPHALEXIN MONOHYDRATE

DMF 135881998

ACS DOBFAR SPACEPHALEXIN MONOHYDRATE

DMF 136121998

ORCHID PHARMA LTDCEPHALEXIN USP

DMF 151062000

LUPIN LTDCEPHALEXIN USP

DMF 172772004

APITORIA PHARMA PRIVATE LTDCEPHALEXIN USP

DMF 176042004

APITORIA PHARMA PRIVATE LTDCEPHALEXIN USP (ENZYMATIC ROUTE)

DMF 329302019

LUPIN LTDCEPHALEXIN USP (ENZYMATIC)

DMF 413572025

GLAXO LABORATORIES SAInactiveCEPHALEXIN

DMF 18201971

ELI LILLY AND COInactiveCEPHALEXIN HYDROCHLORIDE,BULK

DMF 60901985

ELANCO QUIMICA LIMITADAInactiveCEPHALEXIN DISOLVATE

DMF 98891992

LILLY RESEARCH LABORATORIESInactiveCEPHALEXIN MONOHYDRATE

DMF 133851998

LARKInactiveCEPHALEXIN MONOHYDRATE

DMF 135191998

ISFInactiveCEPHALEXIN MONOHYDRATE

DMF 135341998

ANTIBIOTICOSInactiveCEPHALEXIN MONOHYDRATE

DMF 135641998

DISTA PRODUCTS CO DIV ELI LILLY AND COInactiveCEPHALEXIN

DMF 136101998

BRISTOL MYERS SQUIBB COInactiveCEPHALEXIN

DMF 137231998

YOSHITOMI PHARMACEUTICAL INDUSTRIES LTDInactiveCEPHALEXIN

DMF 137151998

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveCEPHALEXIN

DMF 137191998

SQUIBB MFGInactiveCEPHALEXIN

DMF 137201998

BENZEX LABORATORIES LTDInactiveCEPHALEXIN

DMF 137331998

BIOCHEMIE SAInactiveCEPHALEXIN

DMF 137471998

LUPIN LTDInactiveCEPHALEXIN

DMF 137521998

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveCEPHALEXIN USP

DMF 137591998

TAIWAN BIOTECH CO LTDInactiveCEPHALEXIN

DMF 137811998

JK DRUGS AND PHARMACEUTICALS LTDInactiveCEPHALEXIN USP

DMF 142661999

LILLY RESEARCH LABORATORIES DIV ELI LILLY AND COInactiveCEPHALEXIN MONOHYDRATE BULK

DMF 149202000

UNIMARK REMEDIES LTDInactiveCEPHALEXIN USP

DMF 183612005

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveCEPHALEXIN USP (COMPACTED)

DMF 191622006

YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDInactiveCEPHALEXIN USP "YUNG SHIN"

DMF 238722010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 250MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — EQ 500MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Approved Prior to Jan 1, 1982